.Merck trumps profits requirements, raises purchases outlook on strong need for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Profit Estimates as Keytruda Sales Increase BloombergMerck Inventory: Pharma Giant Posts Tough End Results, However Overview Falls Short Client's Service DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats income and purchases requirements amid Keytruda asset, but offers blended full-year outlook MarketWatch.